Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rani Therapeutics Holdings (RANI) Other Non-Current Liabilities (2020)

Rani Therapeutics Holdings has reported Other Non-Current Liabilities over the past 1 years, most recently at $320000.0 for Q4 2020.

  • Quarterly results put Other Non-Current Liabilities at $320000.0 for Q4 2020, changed N/A from a year ago — trailing twelve months through Dec 2020 was $320000.0 (changed N/A YoY), and the annual figure for FY2020 was $320000.0, changed.
  • Other Non-Current Liabilities for Q4 2020 was $320000.0 at Rani Therapeutics Holdings.
  • Over the last five years, Other Non-Current Liabilities for RANI hit a ceiling of $320000.0 in Q4 2020 and a floor of $320000.0 in Q4 2020.